Raymond Debbane - Apr 28, 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Raymond Debbane
Stock symbol
LXRX
Transactions as of
Apr 28, 2024
Transactions value $
$0
Form type
4
Date filed
4/29/2024, 04:17 PM
Previous filing
Oct 12, 2023
Next filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise $0 +8.03K +0.6% $0.00 1.35M Apr 28, 2024 Direct
holding LXRX Common Stock 5.45M Apr 28, 2024 By Invus US Partners LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise $0 -8.03K -100% $0.00* 0 Apr 28, 2024 Common Stock 8.03K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.